🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Cody McHale

University of North Carolina at Charlotte

ORCID: 0000-0002-1242-2417

Also affiliated with Levine Cancer Institute, Wake Forest University

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Novel multitarget small molecule inhibitor LCI133 and synthetic lethality in endometrial carcinoma via CDK9/PI3K axis.”.

Novel multitarget small molecule inhibitor LCI133 and synthetic lethality in endometrial carcinoma via CDK9/PI3K axis.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e15118

N/A

0.165DataRank · unranked

2 citations

Dhananjaya Pal, Maddeboina Krishnaiah, R. Wendel Naumann, Erin K. Crane, Jubilee Brown +7 more

miR-155 Is a Positive Regulator of FcεRI-Induced Cyclooxygenase-2 Expression and Cytokine Production in Mast Cells

Frontiers in Allergy(2022)10.3389/falgy.2022.835776

N/A

0DataRank · unranked

10 citations

Cody McHale, Jason L. Kubinak, Stuart E. Dryer, Gregorio Gomez, Zahraa Mohammed

Recent advances in multitarget-directed ligands via in silico drug discovery

Drug Discovery Today(2024)10.1016/j.drudis.2024.103904

N/A

0DataRank · unranked

27 citations

Bharath Yada, Shikha Kumari, Cody McHale, Dhananjaya Pal, Donald L. Durden +1 more

Discovery of a “First-in-Class” Selective Multikinase (CDK4/6/9-AURKA/B) Inhibitor, LCI133, for Neuroblastoma

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c01688

N/A

0DataRank · unranked

3 citations

Dhananjaya Pal, Bharath Yada, Cody McHale, Sandeep Kumar Singh, Yashpal S. Chhonker +7 more